Zydus Lifesciences Ltd announced on Friday (November 7) that it has received tentative approval from the US Food and Drug Administration (USFDA) to market Olaparib Tablets, 100 mg and 150 mg. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback